Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1

J Clin Invest. 2024 Aug 15;134(16):e185067. doi: 10.1172/JCI185067.
No abstract available

MeSH terms

  • Animals
  • Humans
  • Mice
  • Neoplasms / immunology
  • Neoplasms / metabolism
  • Neoplasms / radiotherapy
  • Receptor, Anaphylatoxin C5a* / genetics
  • Receptor, Anaphylatoxin C5a* / immunology
  • Receptor, Anaphylatoxin C5a* / metabolism
  • Tumor Microenvironment / immunology

Substances

  • Receptor, Anaphylatoxin C5a
  • C5AR1 protein, human